← Back to Clinical Trials
Recruiting NCT07078188

NCT07078188 The Effect of PEG Use Education on the Care Burden and Quality of Life of Patients' Relatives

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07078188
Status Recruiting
Phase
Sponsor Uludag University
Condition Palliative Care
Study Type INTERVENTIONAL
Enrollment 62 participants
Start Date 2023-07-06
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
PEG trainingControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 62 participants in total. It began in 2023-07-06 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study was planned to evaluate the effects of discharge training on PEG use given to palliative care patients' relatives on the caregiver burden and quality of life of the relatives. The main questions that the study aims to answer are as follows: * How does PEG training given before discharge affect the knowledge level of caregivers on PEG use? * How does PEG training given before discharge affect the caregiver burden? * How does PEG training given before discharge affect the caregiver's caregiver stress? * How does PEG training given before discharge affect the quality of life of the caregivers? The researchers will compare the PEG training given before discharge with a control group that did not receive training in this regard in order to evaluate the effects of PEG training given before discharge on the caregiver burden, caregiver stress and quality of life of the caregivers. The study will use a general information form, the Caregiver Burden Scale, the Caregiver Stress Index Form, the SF 36 Quality of Life Scale, and the Percutaneous Endoscopic Gastrostomy Tube Nutrition Information Scale for Caregivers. Participants: * Face-to-face interviews will be conducted with caregivers at 0, 1, and 3 months. * The forms used in the study will be filled out at each interview. * The intervention group will be trained only at the first interview.

Eligibility Criteria

Inclusion Criteria: * The caregiver must be over 18 years old * The caregiver must be willing and able to participate in the study * The caregiver must be primarily responsible for the patient's care * The patient they are caring for must be receiving palliative care * The patient they are caring for must be receiving PEG feeding * The patient they are caring for must be over 18 years old * The patient they are caring for must have been diagnosed with stroke at least six months ago * The caregiver must have a mini mental test score of 25 points or more * The Beck depression scale score must be under 17 points * The caregiver must have a score of over 16 points on the Readiness to Provide Care Scale Exclusion Criteria: * The caregiver is under the age of 18 * The caregiver is not willing and able to participate in the research * The caregiver has a physical disability or serious health problem that makes it difficult to provide care * The patient they are caring for is under the age of 18 * The patient they are caring for has been diagnosed with cancer, endocrine system or GI disease * The caregiver has a mini mental test score of less than 25 * The Beck depression scale score is 17 points or higher * The caregiver has scored 16 or lower on the Readiness to Provide Care Scale * The caregiver has communication problems * The caregiver has been diagnosed with depression or psychiatric disorder * The caregiver is receiving psychotherapy/psychological support * The caregiver is taking antidepressants and/or anxiolytics * The caregiver has sensory loss related to vision and hearing

Contact & Investigator

Central Contact

Hicran Yıldız

✉ hicran_yildiz@yahoo.com

📞 +90 2242942450

Principal Investigator

Hicran Yıldız, Prof.Dr.

PRINCIPAL INVESTIGATOR

Bursa Uludag Unversity

Frequently Asked Questions

Who can join the NCT07078188 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Palliative Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07078188 currently recruiting?

Yes, NCT07078188 is actively recruiting participants. Contact the research team at hicran_yildiz@yahoo.com for enrollment information.

Where is the NCT07078188 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07078188 clinical trial?

NCT07078188 is sponsored by Uludag University. The principal investigator is Hicran Yıldız, Prof.Dr. at Bursa Uludag Unversity. The trial plans to enroll 62 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology